Pharmaceutical Courses

Deceptive Claims, Misleading Marketing: 40 States Sue GlaxoSmithKline

Pharma giant GlaxoSmithKline has been hit with yet another marketing violation. The drugmaker has paid $105 million to more than 40 American states who filed suit against GSK for promoting off-label uses for its antidepressants. But financial payouts are proving little more than slaps on the wrist for the repeat offender who continues to engage in illegal promotional strategies.